HALIFAX, NS, March 20, 2025
Agreement will improve access to, and affordability of, drugs for rare diseases
HALIFAX, NS, March 20, 2025 /CNW/ - In Canada, one in 12 people live with a rare disease, and for most people affected, the cost of treatment is�unaffordable. Canadians deserve a health care system that provides timely access to quality health services and medications, including effective drugs for rare diseases, regardless of where they live or their ability to pay.
Advertisement
Today, the Honourable Kamal Khera, Canada's Minister of Health, and the Honourable Michelle Thompson, Nova Scotia's Minister of Health and Wellness, announced a bilateral agreement investing over $39 million to improve access to selected new drugs for rare diseases, and to support enhanced access to existing drugs, early diagnosis, and screening.
Advertisement
The first step in this bilateral agreement will be to deliver funding to support the province for the following six drugs under the National Strategy for Drugs for Rare Diseases:
The names of other drugs on the common list will be published�online�on a drug-by-drug basis following the conclusion of the pan-Canadian Pharmaceutical Alliance price negotiations for each drug.�In addition, Nova Scotia is committing through this agreement to work with Canada and other provinces and territories on developing and implementing a plan for improving screening and diagnostics for rare diseases.
The Government of Canada remains committed to working with provinces and territories to improve health care for all Canadians, including access to affordable prescription medications and better health outcomes for everyone.
Quotes"This�agreement is another step toward�building a stronger public health system for the people of Nova Scotia. By investing in�drugs for rare diseases, this agreement will�improve affordability and access to medications, early diagnosis, and screening, so that people in Nova Scotia with rare diseases have the best health outcomes possible."
The Honourable Kamal KheraMinister of Health
"This significant investment of over $39 million, through the Government of Canada's bilateral agreement with Nova Scotia, represents a crucial step forward in ensuring Canadians with rare diseases have access to medications they need. We are committed to building a healthcare system where cost and location are not barriers to essential treatment, and this agreement delivers on that promise by providing access to vital drugs and improving early diagnosis and screening. This is about ensuring dignity and quality of life for all Canadians facing the challenges of rare diseases."
The Honourable Kody BloisMinister of Agriculture and Agri-Food and Rural Economic Development
"Nova Scotia is pleased to partner with the federal government to better support Nova Scotians living with rare diseases. This agreement helps support access to medications for rare diseases, improvements to screening and diagnostics, and work to strengthen data and evidence for decision making."
The Honourable Michelle ThompsonNova Scotia's Minister of Health and Wellness�
Quick Facts
Related Products
Associated Links
SOURCE Health Canada (HC)
